PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,046,402 | -21.2% | 5,522,401 | +0.0% | 0.05% | -20.0% |
| Q2 2023 | $72,363,542 | +17.6% | 5,519,721 | +0.3% | 0.06% | +11.1% |
| Q1 2023 | $61,520,421 | +32.6% | 5,502,721 | 0.0% | 0.05% | +28.6% |
| Q4 2022 | $46,387,938 | -48.7% | 5,502,721 | +1.3% | 0.04% | -52.3% |
| Q3 2022 | $90,510,000 | +13.9% | 5,432,751 | +0.7% | 0.09% | +23.9% |
| Q2 2022 | $79,453,000 | -41.2% | 5,397,621 | -0.9% | 0.07% | -30.4% |
| Q1 2022 | $135,115,000 | -14.8% | 5,445,991 | +10.2% | 0.10% | -7.3% |
| Q4 2021 | $158,551,000 | +48.2% | 4,943,891 | +66.3% | 0.11% | +44.7% |
| Q3 2021 | $106,993,000 | +23.8% | 2,973,691 | +51.8% | 0.08% | +31.0% |
| Q2 2021 | $86,446,000 | +58.6% | 1,959,343 | +64.4% | 0.06% | +52.6% |
| Q1 2021 | $54,522,000 | +7.8% | 1,192,000 | +62.7% | 0.04% | 0.0% |
| Q4 2020 | $50,557,000 | – | 732,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |